Beauty Products Manufacturers in India: A Sourcing Guide for Brands

India produces roughly $20 billion worth of cosmetics and personal care products annually, placing the country among the top six global manufacturing hubs for beauty — ahead of South Korea by volume, trailing China by a significant margin. That figure gets cited often. What rarely gets explained is what it actually means for a brand trying to find a manufacturer: what certifications matter, which tiers exist, and where sourcing agreements fall apart.

This guide covers the real structure of Indian beauty manufacturing, the regulatory framework manufacturers are required to operate under, and the specific failure modes that brands encounter most often.

Note: Regulatory requirements vary by product type, export destination, and jurisdiction. This article does not constitute legal or business advice — consult a licensed attorney or regulatory consultant before making sourcing decisions.

The Three-Tier Structure of Indian Beauty Manufacturing

Indian cosmetics manufacturing doesn’t operate as a monolith. It breaks into three recognizable tiers, each with different capabilities, certifications, and minimum order quantities.

Tier 1 — Large-Scale Domestic Manufacturers includes publicly listed companies producing at industrial volume. These manufacturers typically hold WHO-GMP certification, comply with Schedule M under the Drugs & Cosmetics Act, and export to regulated markets in Europe, the Middle East, and Southeast Asia. They generally don’t take on small contract orders from emerging brands.

Tier 2 — Mid-Size Contract and Private Label Manufacturers forms the largest accessible segment for new brands. These facilities typically carry ISO 22716 (Cosmetic GMP) certification, handle custom formulation requests, and operate with MOQs ranging from 500 to 5,000 units per SKU depending on category and complexity.

Tier 3 — Small Regional Formulators covers thousands of smaller manufacturers concentrated in Gujarat, Maharashtra, Delhi NCR, and Tamil Nadu. Quality controls, certifications, and export capabilities vary widely at this tier.

Where the Volume Actually Comes From

The majority of India’s beauty manufacturing volume — by units — comes from hair care and skin care categories. India accounts for a significant share of global fairness cream production. Hair oil manufacturing, anchored by Marico’s Parachute brand infrastructure, represents another substantial portion of total output.

Color cosmetics and prestige skin care were historically smaller in India’s manufacturing mix. That’s shifting. The rise of homegrown D2C brands like Sugar Cosmetics and Plum has driven real investment in domestic color cosmetics manufacturing capacity since around 2019, and that investment is showing up in Tier 2 facility capabilities today.

Geographic Clusters and What They Mean for Lead Times

Maharashtra (Mumbai/Pune) and Delhi NCR hold the highest concentration of Tier 2 contract manufacturers. Baddi in Himachal Pradesh has become a significant hub specifically because of tax incentives for pharmaceutical and cosmetics manufacturers — facilities there often produce for both OTC pharmaceutical and cosmetic lines. Gujarat manufacturers tend to dominate bulk commodity production: base oils, surfactants, and commodity formulations sold to other manufacturers rather than directly to brands.

Regulatory Standards Governing Indian Cosmetics Manufacturers

India’s cosmetics regulatory framework is more rigorous than many brands sourcing from the region expect. The primary governing legislation is the Drugs and Cosmetics Act, 1940, substantially updated through the Cosmetics Rules, 2026. The Central Drugs Standard Control Organisation (CDSCO) administers licensing and compliance at the national level.

Under the Cosmetics Rules 2026, all cosmetics manufactured for sale in India must be licensed under Form COS-1. Manufacturers exporting to regulated markets typically also hold WHO-GMP certification, which requires documented manufacturing processes, quality control procedures, and batch testing protocols. Schedule M of the Drugs & Cosmetics Act specifies the Good Manufacturing Practices requirements that licensed facilities must follow — covering personnel qualifications, facility standards, equipment calibration, raw material testing, and finished product release protocols.

What ISO 22716 Actually Covers

ISO 22716 is the international GMP standard specifically for cosmetics. It covers the full production lifecycle: raw material sourcing, manufacturing, packaging, storage, and distribution. A manufacturer holding ISO 22716 certification has had their documented quality systems audited by an accredited third party such as Bureau Veritas, SGS, or Intertek — all active in India.

This certification is about the facility’s systems. It does not guarantee that any particular formula produced there is safe, stable, or regulatory-compliant in your target market. Those are separate verification steps that sit entirely with the brand, not the manufacturer.

Export Compliance Falls on the Brand, Not the Manufacturer

This is where brands most frequently get caught. An Indian manufacturer is responsible for meeting Indian regulatory requirements and holding whatever certifications they claim. They are not responsible for verifying whether your finished product meets EU Cosmetics Regulation No. 1223/2009, US FDA requirements under the Modernization of Cosmetics Regulation Act (MoCRA), or GCC (Gulf Cooperation Council) market standards.

Brands sourcing from India for EU export are responsible for product safety assessments, responsible person designation, and CPNP (Cosmetic Products Notification Portal) registration. Those obligations don’t transfer to the manufacturer regardless of how the sourcing agreement is worded.

Ayurvedic Claims: A Separate Regulatory Track

Products marketed as Ayurvedic in India fall under the Drugs & Cosmetics Act but are regulated differently — under Ayurvedic, Siddha, and Unani (ASU) drug provisions rather than standard cosmetics licensing. Manufacturers like Kama Ayurveda, Biotique, and Forest Essentials producing Ayurvedic formulations typically hold separate ASU manufacturing licenses in addition to standard cosmetics certifications.

If you’re planning to market products as Ayurvedic in export markets, regulatory recognition of that claim varies significantly by country. EU and US regulatory frameworks don’t recognize Ayurvedic as a product category — the product will be assessed as a cosmetic or drug based on its claims and ingredient profile, regardless of the label designation. This is not legal advice — consult a licensed attorney familiar with your target market’s regulatory requirements.

Contract Manufacturing vs. Private Label vs. White Label

These three terms get used interchangeably by manufacturers and sourcing agents. They shouldn’t be. White label means you buy an existing formula as-is and apply your branding. Private label means a manufacturer modifies an existing base formula to your specifications. Contract manufacturing means you own or co-develop a proprietary formula and the manufacturer produces it under your IP.

For brands entering Indian manufacturing, white label is fastest and lowest-differentiation. If formula exclusivity matters — meaning no other brand can order your exact product — you need contract manufacturing with a clear IP ownership clause. Most Tier 2 Indian manufacturers offer all three models. Whether your agreement actually protects exclusivity is a separate question that depends entirely on contract language. Consult a licensed attorney before signing formula ownership agreements.

Where Sourcing Relationships With Indian Manufacturers Break Down

These failure modes are consistent enough across reported sourcing experiences to be predictable. They’re not hypothetical risks.

1. Stability testing gaps. A manufacturer can produce a formula that tests fine at production. Many Tier 2 facilities lack robust accelerated stability testing infrastructure — the 6-to-12-month testing that determines whether your moisturizer separates under transit heat or your vitamin C serum oxidizes on shelf. Tier 1 manufacturers typically have this capability. Many Tier 2 facilities do not. Ask specifically for stability protocol documentation before signing.
2. Undisclosed raw material substitution. Manufacturers sometimes switch raw material suppliers mid-production run when their preferred supplier has availability or pricing issues. If your formula depends on a specific grade or source of an ingredient, lock that in contractually with Certificate of Analysis requirements per batch.
3. MOQ creep after initial orders. A manufacturer quotes 500 units to win your business. After two production runs, they raise it to 2,000 citing efficiency requirements. This happens regularly. Get MOQ guarantees in writing for at least 18 to 24 months before committing to a manufacturing relationship.
4. Label compliance for export markets. Manufacturers will produce labels to your specifications. They will not review those specifications for compliance with EU INCI naming conventions, US FDA labeling rules, or GCC Arabic language requirements. Label compliance is your responsibility at every stage.
5. IP ownership ambiguity on custom formulas. Unless your contract explicitly assigns formula IP to you, some manufacturers treat custom-developed formulas as their proprietary asset. Courts in India have generally found that formula ownership depends on what the contract specifies. Specify it clearly. This is not legal advice — consult a licensed attorney for any IP agreements.
6. Lead time inflation at production scale. Sample and small-batch lead times from Indian manufacturers are often 2 to 4 weeks. Full commercial production runs from Tier 2 manufacturers commonly run 8 to 14 weeks. That gap surprises brands planning their first large order and can create serious inventory gaps.

When India Is the Right Manufacturing Choice — and When It Isn’t

Where Indian manufacturers have a genuine advantage

• Your product positioning is Ayurvedic, herbal, or botanical-forward — raw material supply chains, formulation expertise, and existing regulatory recognition are concentrated in India for these categories
• Your target markets are South Asia, Southeast Asia, the Middle East, or Africa — logistics relationships, import documentation experience, and trade routes are well-optimized
• You need mid-scale production (5,000 to 100,000 units per SKU per run) at competitive unit economics — Indian manufacturing typically runs 20 to 40% cheaper than equivalent GMP-certified EU production at this volume range
• Your formulations rely on neem, turmeric, ashwagandha, brahmi, or other Ayurvedic botanicals — Indian manufacturers have sourcing depth and raw material quality controls that competitors in other regions rarely match

Where other manufacturing regions hold the edge

• You need very small initial runs under 200 units with fast iteration cycles — Korean OEM manufacturers at this scale typically offer faster sample turnaround and more flexible micro-batch capabilities
• Your formulas require proprietary delivery technologies or specialty actives licensed from EU or US ingredient companies — those supply chains aren’t well-developed in India
• Your primary market is Japan or South Korea, where import documentation requirements are highly specific and Indian manufacturers have limited experience navigating those compliance pathways

The Comparison That Actually Matters: India vs. China vs. South Korea

For a brand building a botanical or Ayurvedic line targeting Western markets, India paired with a qualified regulatory consultant in your target market is a defensible manufacturing strategy. For trend-driven formulations where speed to shelf and frequent reformulation matter, South Korea remains faster. For commodity volume where unit cost drives every decision, China still dominates at scale.

Manufacturers worth beginning conversations with for export-oriented contract production — based on documented export track record and verifiable certification status — include Lotus Herbals’ OEM division, Emami’s contract manufacturing arm, and several Tier 2 facilities in Baddi that regularly produce for both domestic FMCG and international export clients. Current certification verification and a review of their recent batch records remain standard due diligence before any production commitment, regardless of what sales materials state.